Daniel Dayanand Fenn acquired 2,000 equity shares of Hannah Joseph Hospital in the open market on September 18, 2026. The transaction increased his individual holding to 12,015 shares, representing 0.053% of the company’s total voting capital.

The acquisition was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Fenn, a member of the promoter group, purchased the shares directly from the market rather than through a preferential allotment or rights issue.

Shareholding Structure

Fenn’s post-transaction holding stands at 12,015 shares. He had previously held 10,015 shares, accounting for 0.044% of the equity capital. The purchase adds 0.009% to his individual stake.

No shares were encumbered, pledged, or subject to non-disposal undertakings following the transaction. There were no warrants or convertible securities involved.

Promoter Group Holdings

Fenn acts in concert with five other individuals: Dr. Moses Joseph Arunkumar, Dr. Fenn Kavitha Fenn Arunkumar, Dr. Arunkumar Nalina, Mr. Noyel Arunkumar, and Mr. James Prabhukumar Moses. Collectively, the promoter group’s holding increased from 1,62,26,400 shares (71.484%) to 1,62,28,400 shares (71.493%).

Dr. Moses Joseph Arunkumar remains the largest shareholder within the group, holding 1,57,54,925 shares, or 69.41% of the total capital. His stake remained unchanged during this period.

What the Numbers Show

The promoter group controls over 71% of the company’s voting power, with Dr. Moses Joseph Arunkumar alone holding nearly 70% of the equity. This high concentration indicates that control rests firmly with a single individual within the promoter circle, leaving minimal free float for public trading relative to total capital.

Hannah Joseph Hospital shareholders approved the adoption of audited financial statements for the financial year ended March 31, 2026, and a final dividend of ₹2 per equity share at its 15th Annual General Meeting held on July 15, 2026. The meeting, conducted via Video Conferencing and Other Audio-Visual Means (OAVM), also saw the re-appointment of Dr. (Ms.) Arunkumar Nalina as a Non-Executive Director liable to retire by rotation. The voting results were submitted to BSE Limited pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The remote e-voting process, facilitated by National Securities Depository Limited (NSDL), commenced on July 12, 2026, and concluded on July 14, 2026. Members who had not cast their votes remotely were permitted to vote electronically during the meeting. The scrutinizer for the proceedings was Mr. Santhanamarimuthu Rajaguru of M/s. S. Rajaguru & Associates, who confirmed that all three resolutions were passed with the requisite majority.

Voting Outcomes

All three ordinary business items were passed with 100% of the votes polled in favour. A total of 17,400,415 votes were polled across the resolutions, representing 76.66% of the total outstanding shares. There were no votes cast against any of the resolutions, and no invalid votes were recorded.

Key Attendees

The meeting was chaired by Dr. Moses Joseph Arunkumar, Chairman & Managing Director. Key managerial personnel and statutory auditors were present. The requisite quorum was met, and the meeting commenced at 12:00 Noon (IST), concluding at 1:02 P.M. (IST). The consolidated scrutinizer's report has been made available on the company's website.